VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TER
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TERTeradyne, Inc.
$436.86$68.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTERFinancials

Teradyne, Inc. (TER) Financials

30Y historyFree accessUpdated daily

Revenue growth accelerated to 87.0% in 2026Q1, while structural improvements pushed gross margins to 60.9% compared to the 56-59% range observed throughout 2024.

TER Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue3.79B3.19B2.82B2.68B3.16B3.7B3.12B2.29B2.1B2.14B1.75B1.64B1.65B1.43B1.66B1.43B1.57B819.41M1.11B1.1B1.36B1.05B1.41B1.35B1.22B1.44B3.04B1.79B1.49B1.27B1.17B
Revenue Growth %30.32%13.13%5.36%-15.17%-14.79%18.63%36.01%9.24%-1.68%21.87%6.93%-0.5%15.4%-13.81%15.93%-8.75%91.13%-25.98%0.43%-18.73%29.77%-25.89%4.24%10.69%-15.16%-52.67%69.97%20.26%17.6%8.08%-1.63%
Cost of Goods Sold1.56B1.32B1.17B1.14B1.29B1.5B1.34B955.14M880.41M915.15M794.64M723.93M769.02M619.13M770.71M717.24M708.58M507.77M608.85M588.85M704.37M650.05M749.34M953.97M989.57M1.18B1.67B961.4M870.8M675.2M724.62M
COGS % of Revenue-41.45%41.52%42.58%40.82%40.41%42.79%41.62%41.91%42.83%45.32%44.15%46.67%43.36%46.52%50.19%45.24%61.97%55%53.42%51.93%62.2%53.14%70.51%80.96%82.04%54.85%53.68%58.47%53.32%61.85%
Gross Profit2.23B1.87B1.65B1.54B1.87B2.21B1.79B1.34B1.22B1.22B958.61M915.64M878.81M808.8M886.04M711.82M857.58M311.63M498.19M513.43M651.88M395.06M660.88M398.9M232.67M258.77M1.37B829.5M618.4M591.1M446.99M
Gross Margin %58.79%58.55%58.48%57.42%59.18%59.59%57.21%58.38%58.09%57.17%54.68%55.85%53.33%56.64%53.48%49.81%54.76%38.03%45%46.58%48.07%37.8%46.86%29.49%19.04%17.96%45.15%46.32%41.53%46.68%38.15%
Gross Profit Growth %-13.28%7.3%-17.7%-15.39%23.57%33.28%9.79%-0.09%27.42%4.69%4.19%8.66%-8.72%24.47%-17%175.19%-37.45%-2.97%-21.24%65.01%-40.22%65.68%71.44%-10.09%-81.17%65.67%34.14%4.62%32.24%-17.93%
Operating Expenses1.21B1.17B1.06B1.04B1.04B1.01B857.33M800.05M731.37M686.75M661.35M667.59M682.12M616.06M606.39M473.58M446.45M397.56M816.16M455.19M485.45M462.36M504.37M504.06M584.3M558.74M663.48M571.4M484.5M415.8M324.2M
OpEx % of Revenue-36.82%37.42%38.7%32.81%27.17%27.47%34.86%34.81%32.14%37.72%40.72%41.4%43.14%36.6%33.14%28.51%48.52%73.72%41.29%35.79%44.24%35.77%37.26%47.81%38.79%21.8%31.91%32.53%32.84%27.67%
Selling, General & Admin656.46M644.07M617.05M577.32M558.1M547.56M464.77M437.08M390.67M348.91M316.54M306.31M319.71M279.56M277.02M232.09M225.33M200.43M247.79M250.84M283.01M245.99M254.41M249.46M290.38M270.08M362.56M256.4M212.9M194.1M180.26M
SG&A % of Revenue-20.19%21.88%21.57%17.69%14.79%14.89%19.05%18.6%16.33%18.05%18.68%19.4%19.58%16.72%16.24%14.39%24.46%22.38%22.76%20.87%23.54%18.04%18.44%23.76%18.75%11.91%14.32%14.3%15.33%15.39%
Research & Development521.97M504.6M460.88M418.09M440.59M427.61M374.96M322.82M301.5M307.31M292.16M292.25M291.64M264.06M255.87M201.02M191.86M164.84M218.06M204.34M202.44M216.37M249.97M254.6M293.92M288.66M300.92M228.6M195.2M162.5M143.93M
R&D % of Revenue-15.82%16.34%15.62%13.96%11.55%12.01%14.07%14.35%14.38%16.66%17.82%17.7%18.49%15.44%14.07%12.25%20.12%19.7%18.54%14.93%20.7%17.73%18.82%24.05%20.04%9.89%12.76%13.11%12.83%12.28%
Other Operating Expenses4M25.78M-22.78M40.28M36.52M30.77M17.6M40.15M39.19M30.53M52.65M69.03M70.77M72.45M73.51M40.47M29.25M32.3M350.31M0000000086.4M76.4M59.2M0
Operating Income1.02B693.4M593.79M501.07M831.94M1.2B928.41M553.65M473.8M525.34M-62.97M242.97M96.42M190.66M287.37M231.5M414.94M-122.42M-380.74M42.21M202.47M-84.95M155.3M-176.45M-555.8M-352.85M710.76M258.1M133.9M175.3M122.8M
Operating Margin %26.91%21.74%21.06%18.72%26.37%32.43%29.74%24.12%22.55%24.59%-3.59%14.82%5.85%13.35%17.35%16.2%26.49%-14.94%-34.39%3.83%14.93%-8.13%11.01%-13.04%-45.47%-24.49%23.35%14.41%8.99%13.84%10.48%
Operating Income Growth %-16.78%18.5%-39.77%-30.71%29.33%67.69%16.85%-9.81%934.28%-125.92%151.98%-49.43%-33.65%24.13%-44.21%438.94%67.85%-1002.08%-79.15%338.35%-154.7%188.01%68.25%-57.52%-149.64%175.38%92.76%-23.62%42.76%-49.75%
EBITDA1.12B820.12M713.53M611.95M942.61M1.33B1.06B674.31M587.02M633.42M57.04M383.74M248.97M341.35M432.88M338.18M508.45M-16.34M-285.98M109.7M276.01M6.22M255.43M-23.96M-396.12M-214.18M812.63M344.5M210.3M234.5M173.7M
EBITDA Margin %29.53%25.71%25.3%22.87%29.88%35.82%33.8%29.38%27.94%29.65%3.25%23.4%15.11%23.9%26.13%23.66%32.46%-1.99%-25.83%9.95%20.35%0.6%18.11%-1.77%-32.41%-14.87%26.7%19.24%14.12%18.52%14.83%
EBITDA Growth %47.4%14.94%16.6%-35.08%-28.92%25.69%56.48%14.87%-7.32%1010.5%-85.14%54.13%-27.06%-21.15%28%-33.49%3211.71%94.29%-360.69%-60.25%4336.7%-97.56%1166.02%93.95%-84.95%-126.36%135.89%63.81%-10.32%35%-39.58%
D&A (Non-Cash Add-back)99.19M126.72M119.74M110.89M110.67M125.48M126.74M120.66M113.22M108.08M120.01M140.77M152.54M150.69M145.51M106.68M93.52M106.08M94.76M67.5M73.54M91.17M100.13M152.49M159.69M138.67M101.86M86.4M76.4M59.2M50.9M
EBIT1.01B641.37M612.67M529.38M844.1M1.18B925.2M548M489.58M546.08M-51.42M255M102.31M228.02M290.51M238.12M420.8M-119M-368.18M58.25M166.43M-67.3M156.51M-105.17M-351.63M-299.97M710.76M258.1M133.9M175.3M122.8M
Net Interest Income-775K10.83M21.18M23.54M2.66M-15.19M-18.2M-5.23M-1.32M-3.86M5.66M5.34M-675K-21.97M-20.44M-17.08M-18.59M-20.22M-1.68M000000000000
Interest Income13.78M18.85M24.77M27.35M6.38M2.63M5.98M16.99M20.46M17.8M9.3M7.21M6.26M4.13M4.09M6.62M5.86M3.42M12.56M000000000000
Interest Expense14.55M8.02M3.59M3.81M3.72M17.82M24.18M22.22M21.78M21.66M3.64M1.88M6.93M26.1M24.53M23.69M24.45M23.63M14.24M000000000000
Other Income/Expense-27.72M-60.06M8.09M24.5M8.45M-39.77M-27.39M-27.88M-6M-931K7.91M10.15M-1.05M11.26M-13.67M-17.08M-18.59M-20.22M-1.68M37.04M33.56M1.56M-829K-9.74M-5.14M26.69M28.88M15.8M12M18M16.87M
Pretax Income991.51M633.35M601.88M525.57M840.38M1.16B901.01M525.77M467.8M524.41M-55.06M253.12M95.38M201.92M265.98M218.64M396.35M-142.64M-386.02M79.24M230.4M-80.14M154.47M-186.19M-560.95M-326.15M739.65M273.9M145.9M193.3M139.66M
Pretax Margin %26.18%19.85%21.34%19.64%26.64%31.35%28.87%22.91%22.27%24.54%-3.14%15.44%5.79%14.14%16.05%15.3%25.31%-17.41%-34.87%7.19%16.99%-7.67%10.95%-13.76%-45.9%-22.64%24.3%15.29%9.8%15.26%11.92%
Income Tax132.84M79.3M59.5M76.82M124.88M146.37M116.87M58.3M16.02M266.72M-11.64M46.65M14.1M36.98M48.93M-129.54M16.66M-8.8M12.58M7.36M27.87M-19.73M21.85M7.8M157.52M-123.94M221.89M82.2M43.8M65.7M46.09M
Effective Tax Rate %13.4%12.52%9.89%14.62%14.86%12.61%12.97%11.09%3.42%50.86%21.14%18.43%14.79%18.31%18.4%-59.25%4.2%6.17%-3.26%9.29%12.1%24.62%14.14%-4.19%-28.08%38%30%30.01%30.02%33.99%33%
Net Income854.06M554.05M542.37M448.75M715.5M1.01B784.15M467.47M451.78M257.69M-43.42M206.48M81.27M164.95M217.05M349.44M379.73M-133.84M-397.83M71.81M198.76M-46.3M165.24M-193.99M-718.47M-202.22M453.62M191.69M102.12M127.61M93.57M
Net Margin %22.55%17.37%19.23%16.77%22.68%27.4%25.12%20.37%21.51%12.06%-2.48%12.59%4.93%11.55%13.1%24.45%24.25%-16.33%-35.94%6.51%14.65%-4.43%11.72%-14.34%-58.78%-14.04%14.9%10.7%6.86%10.08%7.99%
Net Income Growth %48%2.15%20.86%-37.28%-29.48%29.39%67.74%3.47%75.32%693.47%-121.03%154.06%-50.73%-24%-37.89%-7.98%383.73%66.36%-654%-63.87%529.23%-128.02%185.18%73%-255.3%-144.58%136.64%87.72%-19.98%36.37%-41.25%
Net Income (Continuing)858.67M554.05M542.37M448.75M715.5M1.01B784.15M467.47M451.78M257.69M-43.42M206.48M81.27M164.95M217.05M343.96M379.69M-133.84M-395M71.88M208.16M-63.66M132.62M-193.99M-718.47M-202.22M517.75M191.7M102.1M127.6M93.57M
Discontinued Operations000000000000000000000032.62M00000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)5.423.483.322.734.225.534.282.602.351.28-0.210.970.370.700.941.601.73-0.77-2.330.421.010.460.84-1.03-3.93-1.152.511.070.300.370.55
EPS Growth %52.7%4.82%21.61%-35.31%-23.69%29.21%64.62%10.64%83.59%709.52%-121.65%162.16%-47.14%-25.53%-41.25%-7.51%324.68%66.95%-654.76%-58.42%119.57%-45.24%181.55%73.79%-241.74%-145.82%134.58%256.67%-18.92%-32.73%5.77%
EPS (Basic)-3.493.412.914.526.154.722.742.411.30-0.210.980.400.861.161.972.11-0.77-2.330.421.020.460.85-1.03-3.93-1.152.621.120.310.380.55
Diluted Shares Outstanding157.64M157.65M163.31M164.3M169.73M183.63M183.04M179.46M192.6M201.64M202.58M213.32M222.55M235.6M230.25M226.82M226.81M173.6M170.59M185.37M204.41M196.28M196.71M188.34M182.82M175.83M181.01M178.55M343.86M345.38M339.89M
Basic Shares Outstanding156.41M156.41M159.08M154.31M158.43M164.96M166.12M170.43M187.67M198.07M202.58M211.54M202.91M190.77M186.88M184.68M179.92M173.6M170.59M184.02M194.73M196.28M194.4M188.34M182.82M175.83M173.31M170.52M335.29M345.38M339.89M
Dividend Payout Ratio-13.77%14.09%15.13%9.74%6.5%8.48%13.11%14.9%21.52%-24.56%46.05%------------------

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Geopolitical supply chain exposure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Surge Driven by AI

According to recent quarterly filings, Teradyne's revenue growth accelerated sharply to 87.0% in 2026Q1, marking a significant departure from the mid-single-digit growth observed in previous periods and suggesting a robust demand inflection tied to high-end semiconductor testing requirements for AI-related compute architectures.

The dramatic top-line expansion appears to be a direct consequence of increased test intensity required for advanced nodes and HBM integration. Investors should monitor whether this trajectory is sustainable or if it represents a front-loading of capital expenditure by major OSATs ahead of broader industry cycles.

Structural Margin Expansion Amid Complexity

As reported in financial statements, Teradyne achieved a gross margin of 60.9% in 2026Q1, reflecting a structural improvement over the 56-59% range maintained throughout 2024, which suggests the company is successfully capturing premium pricing for its highly specialized test platforms in a complex semiconductor environment.

This margin expansion indicates that the company's proprietary software ecosystem and high-end hardware are providing significant pricing power. The ability to maintain these levels despite potential inflationary pressures on specialized components suggests a strong competitive moat in the ATE duopoly.

Operating Leverage Scaling With Volume

Based on the provided income statement data, operating income surged to $473.0M in 2026Q1, demonstrating significant operating leverage as the operating margin expanded to 36.9% compared to the 13-20% range seen in the prior year, indicating efficient management of fixed costs during periods of high revenue growth.

The disproportionate growth in operating income relative to revenue suggests that Teradyne's cost structure is highly scalable once volume thresholds are met. This efficiency implies that the company is well-positioned to maximize profitability during cyclical upswings without requiring proportional increases in SG&A or R&D spending.

Disciplined R&D Investment Strategy

Analysis of the income statement reveals that R&D expenses remained relatively contained at $135.6M in 2026Q1, representing a declining percentage of total revenue, which suggests management is maintaining expense discipline while simultaneously benefiting from the high-volume throughput of its current product generation.

While R&D is essential for maintaining the competitive edge in ATE, the current trend suggests that the company is successfully leveraging its existing intellectual property base. Investors should watch for any future spikes in R&D that might indicate a need to pivot toward new, unproven transistor architectures.

TER — Frequently Asked Questions

Quick answers to the most common questions about buying TER stock.

What was Teradyne, Inc.'s (TER) revenue in 2025?

For fiscal year 2025, Teradyne, Inc. (TER) reported total revenue of $3.19B. This represents a 172.3% increase compared to $1.17B in 1996.

Is Teradyne, Inc. (TER) profitable?

Teradyne, Inc. (TER) is profitable, generating $554.0M in net income for the fiscal year ending 2025 with a net profit margin of 17.4%.

What is Teradyne, Inc.'s operating profit margin?

Teradyne, Inc. (TER) reported an operating income of $693.4M, resulting in an operating profit margin of 21.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Teradyne, Inc.'s gross profit and gross margin?

Teradyne, Inc. (TER) generated $1.87B in gross profit for the year, representing a gross profit margin of 58.6%. This demonstrates the company's core pricing power and production efficiency.